Abaci Okay, Kocas Cuneyt, Oktay Veysel, Arslan Sukru, Turkmen Yusuf, Bostan Cem, Coskun Ugur, Yildiz Ahmet, Ersanli Murat
Department of Cardiology, Cardiology Institute of Istanbul University, Istanbul, Turkey. Email:
Department of Cardiology, Cardiology Institute of Istanbul University, Istanbul, Turkey.
Cardiovasc J Afr. 2017 Jan/Feb;28(1):4-7. doi: 10.5830/CVJA-2016-041.
We aimed to investigate the relationship between myocardial performance index (MPI) and severity of coronary artery disease, as assessed by the Gensini score (GS), in patients with non-ST-segment elevation myocardial infarction (NSTEMI).
Ninety patients with an initial diagnosis of NSTEMI were enrolled in our study. They were divided into tertiles according to the GS: low GS < 19; mid GS > 19 and ≤ 96; and high GS > 96.
The low-, mid- and high-GS groups included 24, 38 and 28 patients, respectively. Clinical features such as gender distribution; body mass index (BMI); prevalence of diabetes mellitus, hypertension and hyperlipidaemia; and smoking status were similar in the three groups. MPI and isovolumic relaxation time were significantly higher in the high-GS group than in the low- and mid-GS groups (p < 0.001 and p = 0.005, respectively). Furthermore, the high-GS group had a significantly lower ejection fraction and ejection time (p = 0.01 and p < 0.001, respectively). MPI was positively correlated with the GS (r = 0.47, p < 0.001), and multivariate regression analysis showed that MPI was an independent predictor of the GS (β = 0.358, p < 0.001).
Patients with NSTEMI who fall within the high-risk group may be identified by means of a simple MPI measurement.
我们旨在研究非ST段抬高型心肌梗死(NSTEMI)患者中心肌性能指数(MPI)与通过Gensini评分(GS)评估的冠状动脉疾病严重程度之间的关系。
90例初诊为NSTEMI的患者纳入我们的研究。根据GS将他们分为三分位数:低GS<19;中GS>19且≤96;高GS>96。
低、中、高GS组分别包括24、38和28例患者。三组患者的临床特征,如性别分布、体重指数(BMI)、糖尿病、高血压和高脂血症患病率以及吸烟状况相似。高GS组的MPI和等容舒张时间显著高于低GS组和中GS组(分别为p<0.001和p = 0.005)。此外,高GS组的射血分数和射血时间显著更低(分别为p = 0.01和p<0.001)。MPI与GS呈正相关(r = 0.47,p<0.001),多变量回归分析显示MPI是GS的独立预测因子(β = 0.358,p<0.001)。
通过简单的MPI测量可能识别出处于高危组的NSTEMI患者。